Published in Arch Dis Child on October 01, 1982
The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev (2012) 2.71
Low maternal exposure to ultraviolet radiation in pregnancy, month of birth, and risk of multiple sclerosis in offspring: longitudinal analysis. BMJ (2010) 2.08
Placenta-specific methylation of the vitamin D 24-hydroxylase gene: implications for feedback autoregulation of active vitamin D levels at the fetomaternal interface. J Biol Chem (2009) 1.50
Bone disease in preterm infants. Arch Dis Child (1989) 0.93
Vitamin D supplementation for northern native communities. Indian and Inuit Health Committee, Canadian Paediatric Society. CMAJ (1988) 0.89
Clinical, biochemical, and radiological manifestations of vitamin D deficiency in newborns presented with hypocalcemia. Indian J Endocrinol Metab (2013) 0.81
Cord blood 25(OH)D levels and the subsequent risk of lower respiratory tract infections in early childhood: the Ulm birth cohort. Eur J Epidemiol (2014) 0.78
Ca2+-binding protein of the human placenta. Characterization, immunohistochemical localization and functional involvement in Ca2+ transport. Biochem J (1985) 0.78
Immune Modulation by Vitamin D and Its Relevance to Food Allergy. Nutrients (2015) 0.78
Clinical assessment of gestational age in the newborn infant. J Pediatr (1970) 16.08
Competitive protein-binding radioassay for 25-hydroxycholecalciferol. J Clin Endocrinol Metab (1971) 4.81
Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D3. Significance of the free 1,25-dihydroxyvitamin D3 concentration. J Clin Invest (1981) 3.15
A sensitive, precise, and convenient method for determination of 1,25-dihydroxyvitamin D in human plasma. Arch Biochem Biophys (1976) 2.23
Human perinatal vitamin D metabolism. I. 25-Hydroxyvitamin D in maternal and cord blood. J Pediatr (1974) 2.17
Elevated 1,25-dihydroxyvitamin D plasma levels in normal human pregnancy and lactation. J Clin Invest (1979) 1.56
Calcium metabolism in newborn infants. The interrelationship of parathyroid function and calcium, magnesium, and phosphorus metabolism in normal, "sick," and hypocalcemic newborns. J Clin Invest (1974) 1.52
Vitamin D homeostasis in the perinatal period: 1,25-dihydroxyvitamin D in maternal, cord, and neonatal blood. N Engl J Med (1980) 1.14
Competitive protein-binding radioassay of 24,25-dihydroxyvitamin D in sera from normal and anephric subjects. Arch Biochem Biophys (1977) 1.13
25-hydroxyvitamin D and its binding protein in maternal and cord serum. J Clin Endocrinol Metab (1977) 1.12
Neonatal parathyroid function: role of gestational age and postnatal age. J Pediatr (1973) 1.06
Hypoparathyroidism during pregnancy: treatment with calcitriol. J Clin Endocrinol Metab (1981) 1.03
Plasma 1,25-dihydroxyvitamin D levels in pregnancy and lactation. Acta Endocrinol (Copenh) (1979) 1.02
Perinatal vitamin D metabolism. IV. Maternal and cord serum 24,25-dihydroxyvitamin D concentrations. J Clin Endocrinol Metab (1978) 0.97
Perinatal parathyroid hormone, vitamin D metabolites, and calcitonin in man. Am J Physiol (1980) 0.97
Serum 1,25-dihydroxyvitamin D concentration in hypophosphatemic vitamin D-resistant rickets. Calcif Tissue Int (1981) 0.96
Concentrations of 24,25-dihydroxyvitamin D and 25-hydroxyvitamin D in paired maternal-cord sera. Am J Obstet Gynecol (1978) 0.91
Fetal calcitropic hormones and neonatal calcium homeostasis. Pediatrics (1980) 0.90
Fetomaternal vitamin D relationships at term. J Pediatr (1980) 0.89
Influence of pregnancy on immunoreactive parathyroid hormone levels. Calcif Tissue Int (1982) 0.87
Maternal and fetal serum 1,25-dihydroxyvitamin D levels at term. J Pediatr (1980) 0.87
Plasma concentrations of calcium, chromium, copper, iron, magnesium, and zinc in maternal and cord blood and their relationship to low birth weight. J Lab Clin Med (1978) 0.86
Normal intrauterine development of the fetus of a woman receiving extraordinarily high doses of 1,25-dihydroxyvitamin D3. J Clin Endocrinol Metab (1980) 0.85
Calcium homeostasis in the fetus. J Dev Physiol (1981) 0.81
The effect of elevated prolactin levels on plasma 1,25-dihydroxyvitamin D and intestinal absorption of calcium. Mayo Clin Proc (1980) 0.79
Effects of hyperprolactinemia on calciotropic hormones. Med Biol (1980) 0.78
The interrelationships among prolactin, 1,25-dihydroxyvitamin D, and parathyroid hormone in humans. J Clin Endocrinol Metab (1979) 0.78
Ionized calcium--its relationship to albumin and total protein. Am J Clin Pathol (1977) 0.77
Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res (1987) 24.27
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell (2001) 11.99
Targeted inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. Endocrinology (2001) 2.87
Hypophosphatemia: mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets. Proc Natl Acad Sci U S A (1976) 2.59
Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome. Cancer Res (1993) 2.48
High-versus low-dose erythropoietin in extremely low birth weight infants. The European Multicenter rhEPO Study Group. J Pediatr (1998) 2.41
Insulin resistance syndrome in a representative sample of children and adolescents from Quebec, Canada. Int J Obes Relat Metab Disord (2004) 2.26
Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res (1999) 2.09
Deficient mineralization of intramembranous bone in vitamin D-24-hydroxylase-ablated mice is due to elevated 1,25-dihydroxyvitamin D and not to the absence of 24,25-dihydroxyvitamin D. Endocrinology (2000) 2.08
Measurement of bone mineral content of the lumbar spine by dual energy x-ray absorptiometry in normal children: correlations with growth parameters. J Clin Endocrinol Metab (1990) 1.83
Osteoblasts isolated from mouse calvaria initiate matrix mineralization in culture. J Cell Biol (1983) 1.80
Increased expression of the c-fos proto-oncogene in bone from patients with fibrous dysplasia. N Engl J Med (1995) 1.78
Osteogenesis imperfecta type VII: an autosomal recessive form of brittle bone disease. Bone (2002) 1.77
Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody. Int J Cancer (1997) 1.69
Linkage disequilibrium analysis in young populations: pseudo-vitamin D-deficiency rickets and the founder effect in French Canadians. Am J Hum Genet (1996) 1.68
Perinatal metabolism of vitamin D. Am J Clin Nutr (2000) 1.67
Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age. J Clin Endocrinol Metab (2000) 1.65
Distribution of mutations in the PEX gene in families with X-linked hypophosphataemic rickets (HYP). Hum Mol Genet (1997) 1.64
Vitamin D deficiency in Iranian mothers and their neonates: a pilot study. Acta Paediatr (2001) 1.60
Mepe, the gene encoding a tumor-secreted protein in oncogenic hypophosphatemic osteomalacia, is expressed in bone. Genomics (2001) 1.60
The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus. J Bone Miner Res (1997) 1.53
Calcium metabolism in newborn infants. The interrelationship of parathyroid function and calcium, magnesium, and phosphorus metabolism in normal, "sick," and hypocalcemic newborns. J Clin Invest (1974) 1.52
Replacement therapy for inherited enzyme deficiency: liver orthotopic transplantation in Niemann-Pick disease type A. Am J Med Genet (1977) 1.51
Static and dynamic bone histomorphometry in children with osteogenesis imperfecta. Bone (2000) 1.46
Use of phosphate and vitamin D to prevent dwarfism and rickets in X-linked hypophosphatemia. N Engl J Med (1972) 1.46
Renal handling of phosphate in vivo and in vitro by the X-linked hypophosphatemic male mouse: evidence for a defect in the brush border membrane. Kidney Int (1978) 1.45
Net calcium absorption in premature infants: results of 103 metabolic balance studies. Am J Clin Nutr (1992) 1.41
cDNA cloning of the murine Pex gene implicated in X-linked hypophosphatemia and evidence for expression in bone. Genomics (1996) 1.41
Evidence for a major gene affecting the transition from normoglycaemia to hyperglycaemia in Psammomys obesus. Heredity (Edinb) (2005) 1.40
Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets. N Engl J Med (1980) 1.37
[Tay-Sachs disease: prenatal detection and diagnosis]. Union Med Can (1972) 1.36
MUC1 gene polymorphism and gastric cancer--an epidemiological study. Glycoconj J (1997) 1.32
Collagen changes in the human uterine cervix at parturition. Am J Obstet Gynecol (1978) 1.30
Relation between hypomineralized periosteocytic lesions and bone mineralization in vitamin D-resistant rickets. Calcif Tissue Int (1983) 1.30
Vitamin D supplementation during pregnancy: effect on neonatal calcium homeostasis. J Pediatr (1986) 1.29
The use of chondrogide membrane in autologous chondrocyte implantation. Knee (2004) 1.26
Lack of specificity of procalcitonin for sepsis diagnosis in premature infants. Lancet (1998) 1.26
Infection by Helicobacter pylori expressing the BabA adhesin is influenced by the secretor phenotype. J Pathol (2008) 1.26
Immunohistochemical study of the expression of MUC6 mucin and co-expression of other secreted mucins (MUC5AC and MUC2) in human gastric carcinomas. J Histochem Cytochem (2000) 1.25
Histomorphometric analysis of sclerotic bone metastases from prostatic carcinoma special reference to osteomalacia. Cancer (1983) 1.23
Alendronate for the treatment of pediatric osteogenesis imperfecta: a randomized placebo-controlled study. J Clin Endocrinol Metab (2010) 1.22
A family of human beta4-galactosyltransferases. Cloning and expression of two novel UDP-galactose:beta-n-acetylglucosamine beta1, 4-galactosyltransferases, beta4Gal-T2 and beta4Gal-T3. J Biol Chem (1997) 1.22
Body composition in appropriate and in small for gestational age infants. Acta Paediatr (1997) 1.21
Osteogenesis imperfecta--clinical and molecular diversity. Eur Cell Mater (2003) 1.20
The mineralization density of iliac crest bone from children with osteogenesis imperfecta. Calcif Tissue Int (1999) 1.19
X-linked hypophosphatemia: effect of calcitriol on renal handling of phosphate, serum phosphate, and bone mineralization. J Clin Endocrinol Metab (1981) 1.15
Structural and cellular changes during bone growth in healthy children. Bone (2000) 1.11
Expression of fully and under-glycosylated forms of MUC1 mucin in gastric carcinoma. Int J Cancer (1998) 1.11
Engineering bone regeneration with bioabsorbable scaffolds with novel microarchitecture. Tissue Eng (1999) 1.07
Late evolution of serum immunoreactive parathyroid hormones, calcitonin and plasma 25-hydroxy cholecalciferol concentrations in very low birthweight infants. Acta Paediatr Scand (1981) 1.07
Second report on chicken genes and chromosomes 2005. Cytogenet Genome Res (2005) 1.05
Lumbar bone mineral content measured by dual energy X-ray absorptiometry in newborns and infants. Acta Paediatr (1992) 1.05
MUC1 gene polymorphism in the gastric carcinogenesis pathway. Eur J Hum Genet (2001) 1.04
Hypoparathyroidism during pregnancy: treatment with calcitriol. J Clin Endocrinol Metab (1981) 1.03
Thirty-three novel COL1A1 and COL1A2 mutations in patients with osteogenesis imperfecta types I-IV. Hum Mutat (2001) 1.02
Preoperative stabilization using high-frequency oscillatory ventilation in the management of congenital diaphragmatic hernia. Crit Care Med (1994) 1.02
Key elements of the BMP/SMAD pathway co-localize with CDX2 in intestinal metaplasia and regulate CDX2 expression in human gastric cell lines. J Pathol (2008) 1.01
Temporal and spatial expression of bone morphogenetic protein-2, -4, and -7 during distraction osteogenesis in rabbits. Bone (2000) 1.00
Development and characterization of an antibody directed to an alpha-N-acetyl-D-galactosamine glycosylated MUC2 peptide. Glycoconj J (1998) 0.99
Linkage mapping by simultaneous screening of multiple polymorphic loci using Alu oligonucleotide-directed PCR. Proc Natl Acad Sci U S A (1992) 0.99
CRTAP deficiency leads to abnormally high bone matrix mineralization in a murine model and in children with osteogenesis imperfecta type VII. Bone (2009) 0.99
Recurrent nephrotic syndrome after transplantation: early treatment with plasmaphaeresis and cyclophosphamide. Pediatr Nephrol (1993) 0.99
The bone formation defect in idiopathic juvenile osteoporosis is surface-specific. Bone (2002) 0.99
Ceftriaxone-associated nephrolithiasis. Nephrol Dial Transplant (1990) 0.98
Osteogenesis imperfecta at the beginning of bone and joint decade. Croat Med J (2001) 0.98
Bone-specific expression of the alpha chain of the nascent polypeptide-associated complex, a coactivator potentiating c-Jun-mediated transcription. Mol Cell Biol (1998) 0.98
X-linked hypophosphataemic rickets: Inadequate therapeutic response to 1,25-dihydroxycholecalciferol. Lancet (1973) 0.98
Mutation rate and pattern of microsatellites in common carp (Cyprinus carpio L.). Genetica (2006) 0.98
Immunohistochemical analysis of ras oncogene p21 product in human gastric carcinomas and their adjacent mucosas. Pathol Res Pract (1992) 0.97
Serum 1,25-dihydroxyvitamin D concentration in hypophosphatemic vitamin D-resistant rickets. Calcif Tissue Int (1981) 0.96
In vitro metabolism of 25-hydroxycholecalciferol by isolated cells from human decidua. J Clin Endocrinol Metab (1985) 0.96
Sporadic gastric carcinomas with microsatellite instability display a particular clinicopathologic profile. Int J Cancer (1995) 0.96
Effect of dietary phosphate deprivation and supplementation of recipient mice on bone formation by transplanted cells from normal and X-linked hypophosphatemic mice. J Bone Miner Res (1992) 0.96
Deficient bone formation in idiopathic juvenile osteoporosis: a histomorphometric study of cancellous iliac bone. J Bone Miner Res (2000) 0.96
Normative data on mineralization density distribution in iliac bone biopsies of children, adolescents and young adults. Bone (2009) 0.96
Dual energy x-ray absorptiometry measurement of bone mineral content in newborns: validation of the technique. Pediatr Res (1992) 0.95
Biosynthesis of cytochalasans. Part 4. The mode of incorporation of common naturally-occurring carboxylic acids into cytochalasin D1. Helv Chim Acta (1975) 0.95
Immunohistochemical expression of oncofetal fibronectin in benign and malignant lesions of the stomach. Eur J Cancer (1993) 0.95
Resolution of severe, adolescent-onset hypophosphatemic rickets following resection of an FGF-23-producing tumour of the distal ulna. Bone (2004) 0.94
Functional studies on purified eosinophils and neutrophils from patients with Schistosoma mansoni infections. Clin Exp Immunol (1980) 0.94
Bone mineral metabolism in the micropremie. Clin Perinatol (2000) 0.94
Congenital hyperparathyroidism and vitamin D deficiency secondary to maternal hypoparathyroidism. Acta Paediatr Scand (1976) 0.94
Vitamin D dependency: replacement therapy with calcitriol? J Pediatr (1981) 0.93
Establishment and characterization of two cell lines derived from human diffuse gastric carcinomas xenografted in nude mice. Virchows Arch (1996) 0.93